Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Mogrify | 2023 | Series A | $10.0M | Cambridge |
| Mach42 | 2023 | Seed | $5.5M | Oxford |
| Fresh Check | 2023 | Seed | $620K | London |
| Phasecraft | 2023 | Series A | $16.5M | London |
| Entia | 2023 | Series A | $20.7M | London |
| NK:IO | 2023 | Seed | $1.5M | London |
| Signaloid | 2023 | Seed | $3.7M | Cambridge |
| PharmEnable | 2023 | Seed | $7.5M | Cambridge |
| LettUs Grow | 2023 | Series A | $3.1M | Bristol |
| TextMine | 2023 | Seed | $3.6M | London |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 51 | Mogrify | Series A | $10.0M | Cambridge, United Kingdom |
| 52 | Mach42 | Seed | $5.5M | Oxford, United Kingdom |
| 53 | Fresh Check | Seed | $620K | London, United Kingdom |
| 54 | Phasecraft | Series A | $16.5M | London, United Kingdom |
| 55 | Entia | Series A | $20.7M | London, United Kingdom |
| 56 | NK:IO | Seed | $1.5M | London, United Kingdom |
| 57 | Signaloid | Seed | $3.7M | Cambridge, United Kingdom |
| 58 | PharmEnable | Seed | $7.5M | Cambridge, United Kingdom |
| 59 | LettUs Grow | Series A | $3.1M | Bristol, United Kingdom |
| 60 | TextMine | Seed | $3.6M | London, United Kingdom |
MogrifyAE will transform the lives of patients with degenerative diseases through a novel class of in vivo reprogramming therapies.
Mach42 is a University of Oxford spin-out commercializing new machine learning technology.
Visible warning of bacterial infection in packaging.
Phasecraft is a quantum computing software developer.
Entia is a medical technology company that specializes in improving access to blood test.
NK:IO is a biotech company that develops novel approaches to natural killer cell-mediated immunotherapy.
Signaloid is a cloud-based computing platform.
PharmEnable has developed a rapid and cost effective way to identify better chemical starting points to drive the discovery.
LettUs Grow design aeroponic irrigation and control technology for greenhouse & vertical farms.
TextMine is the end-to-end AI powered knowledge base for your business critical documents
Bonnet streamlines EV charging by offering one app for drivers and businesses to access any public charger.
RoboK is a computer vision startup with a mission to make all industrial workplaces safe and high-performing with AI.
Echopoint Medical is a medtech company
Abselion is the biological sensor for rapid and cost-effective detection of biological substances.
A med-tech startup that has developed a passive and contactless device for monitoring nocturnal symptoms and environmental metrics at home.
Qkine is a specialist developer and manufacturer of growth factor proteins for stem cell, organoid and cellular agriculture applications
Pathfinder is developing a novel catheter based system that provides a better way for patients to receive haemodialysis for kidney failure.
Cambridge Photon Technology is a developer of organic photovoltaic devices used to enhance next-generation solar technology.
Animal Dynamics Ltd, based in Oxford, UK, is a technology company specialising in the design and manufacture of autonomous vehicles.
Scripta Therapeutics operates as a bio-tech company.
Oxa develops autonomous vehicle software and hardware solutions for industrial mobility automation.
xWatts is an intelligent energy management system that helps commercial buildings reduce costs and emissions.
NoBACZ is pioneering a novel, new precision bandaging platform for the veterinary and human market.
Trismik is an early-stage company specializing in efficient real-world evaluations, particularly for LLMs.
Enhanc3D Genomics is a functional genomics company exploring the 3D organization of DNA in health and disease.
Parkwalk Advisors has invested in 144 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Parkwalk Advisors's top investment sectors include Biotechnology, Software, Health Care, Medical, Life Science. The firm invests across 47 different industry categories.
Among tracked funding rounds, Oxa received $102.6M in a Series D round. Parkwalk Advisors's total known invested capital is $1.1B.
Parkwalk Advisors's average investment size is $12.7M across its portfolio of 144 companies.
Recent Parkwalk Advisors portfolio additions include Mogrify, Mach42, Fresh Check, Phasecraft, Entia. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors